GGrantIndex
← Leaderboards

Angelique Y Louie

California Institute Of Technology

Google Scholar ↗PubMed ↗ORCID ↗
$7,640,729
Attributed
$11,456,157
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2005–24
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$11,456,157 · 11

By mechanism

R01$8,449,871 · 3
R21$1,691,079 · 4
R56$563,731 · 1
R03$445,500 · 1
R25$216,000 · 1
F32$89,976 · 1

Top collaborators

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Research focus

Magnetic Resonance ImagingInterestContrast MediaImaging ProbeImageAnimalsTissuesNanoparticleIn VivoPositron-Emission TomographySurfaceInflammationAffectAnimal ModelUptakeLabelMonitorThrombosisCellsResolutionDetectionBiomarkerImmuneImaging Modality

Grant awards (32)

Nanodisc Platform for 19F-MRI$212,201
R21 · FY2024 · EB · contact PI
Nanodisc Platform for 19F-MRI$272,874
R21 · FY2023 · EB · contact PI
Trackable, Targeted Anticoagulants for Atrial Fibrillation$597,486
R01 · FY2020 · HL · contact PI
Targeted nanoprobes for multiplexed 19F-MRI of macrophage polarization markers$232,453
R21 · FY2020 · EB · contact PI
Trackable, Targeted Anticoagulants for Atrial Fibrillation$597,486
R01 · FY2019 · HL · contact PI
Targeted nanoprobes for multiplexed 19F-MRI of macrophage polarization markers$188,874
R21 · FY2019 · EB · contact PI
Trackable, Targeted Anticoagulants for Atrial Fibrillation$597,486
R01 · FY2018 · HL · contact PI
Trackable, Targeted Anticoagulants for Atrial Fibrillation$563,731
R56 · FY2017 · HL · contact PI
UCD BME Translational Design and Innovation Program$43,200
R25 · FY2015 · EB · contact PI
Noninvasive imaging of eosinophils$215,421
R21 · FY2014 · AI · contact PI
UCD BME Translational Design and Innovation Program$43,200
R25 · FY2014 · EB · contact PI
Multimodal microPET and microMRI Imaging Instrumentation$998,567
R01 · FY2013 · EB
Noninvasive imaging of eosinophils$167,690
R21 · FY2013 · AI · contact PI
UCD BME Translational Design and Innovation Program$43,200
R25 · FY2013 · EB · contact PI
Multimodal microPET and microMRI Imaging Instrumentation$1,052,834
R01 · FY2012 · EB
UCD BME Translational Design and Innovation Program$43,200
R25 · FY2012 · EB · contact PI
Multimodal microPET and microMRI Imaging Instrumentation$1,079,923
R01 · FY2011 · EB
Nontoxic Si Nanoprobes for Mulitple Biomarker Imaging$325,443
R01 · FY2011 · EB · contact PI
UCD BME Translational Design and Innovation Program$43,200
R25 · FY2011 · EB · contact PI
Multimodal microPET and microMRI Imaging Instrumentation$1,108,983
R01 · FY2010 · EB
Nontoxic Si Nanoprobes for Mulitple Biomarker Imaging$304,722
R01 · FY2010 · EB · contact PI
Multimodal microPET and microMRI Imaging Instrumentation$1,119,029
R01 · FY2009 · EB
Nontoxic Si Nanoprobes for Mulitple Biomarker Imaging$307,800
R01 · FY2009 · EB · contact PI
Nontoxic Si Nanoprobes for Mulitple Biomarker Imaging$36,832
R01 · FY2009 · EB · contact PI
Nontoxic Si Nanoprobes for Mulitple Biomarker Imaging$323,280
R01 · FY2008 · EB · contact PI
Macrophage specific magnetic-fluorescent nanoprobes$216,913
R21 · FY2006 · HL · contact PI
Macrophage specific magnetic-fluorescent nanoprobes$184,653
R21 · FY2005 · HL
MRI Probes for Mapping Retinal Activity In Vivo$148,500
R03 · FY2004 · EY
MRI Probes for Mapping Retinal Activity In Vivo$148,500
R03 · FY2003 · EY
MRI Probes for Mapping Retinal Activity In Vivo$148,500
R03 · FY2002 · EY
AN MRI CONTRAST AGENT THAT DETECTS GENE EXPRESSION$47,348
F32 · FY2001 · GM
AN MRI CONTRAST AGENT THAT DETECTS GENE EXPRESSION$42,628
F32 · FY2000 · GM